Wakako Maruyama

The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients

M. Naoi, W. Maruyama, Wakako Maruyama, 1996, Journal of the Neurological Sciences.

Golden mean to longevity: Rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease

Noriyuki Fuku, Nobutaka Hattori, Yoshikuni Mizuno, 2002, Journal of neuroscience research.

Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells

Y. Akao, M. Naoi, Yukihiro Akao, 2013, Journal of Neural Transmission.

An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells

Ken-ichi Isobe, Toshihiko Osawa, K. Isobe, 2003, Journal of neuroscience research.

Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.

M. Naoi, W. Maruyama, Wakako Maruyama, 2010, Current pharmaceutical design.